Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) + Azelaic Acid Cream + Metronidazole gel + Metronidazole cream + Metronidazole Emulsion + Metronidazole Lotion + Brimonidine Tartrate Gel

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Jan 8, 2015 → Mar 10, 2016

About Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) + Azelaic Acid Cream + Metronidazole gel + Metronidazole cream + Metronidazole Emulsion + Metronidazole Lotion + Brimonidine Tartrate Gel

Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) + Azelaic Acid Cream + Metronidazole gel + Metronidazole cream + Metronidazole Emulsion + Metronidazole Lotion + Brimonidine Tartrate Gel is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT02602470. Target conditions include Rosacea.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT02602470Pre-clinicalCompleted